These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 1418004)
1. Treatment of systemic sclerosis with recombinant interferon-gamma. A phase I/II clinical trial. Freundlich B; Jimenez SA; Steen VD; Medsger TA; Szkolnicki M; Jaffe HS Arthritis Rheum; 1992 Oct; 35(10):1134-42. PubMed ID: 1418004 [TBL] [Abstract][Full Text] [Related]
2. A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels. Polisson RP; Gilkeson GS; Pyun EH; Pisetsky DS; Smith EA; Simon LS J Rheumatol; 1996 Apr; 23(4):654-8. PubMed ID: 8730122 [TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis. Vlachoyiannopoulos PG; Tsifetaki N; Dimitriou I; Galaris D; Papiris SA; Moutsopoulos HM Ann Rheum Dis; 1996 Oct; 55(10):761-8. PubMed ID: 8984943 [TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma in the treatment of systemic sclerosis: a randomized controlled multicentre trial. Grassegger A; Schuler G; Hessenberger G; Walder-Hantich B; Jabkowski J; MacHeiner W; Salmhofer W; Zahel B; Pinter G; Herold M; Klein G; Fritsch PO Br J Dermatol; 1998 Oct; 139(4):639-48. PubMed ID: 9892907 [TBL] [Abstract][Full Text] [Related]
5. Systemic scleroderma. Multicenter trial of 1 year of treatment with recombinant interferon gamma. Hunzelmann N; Anders S; Fierlbeck G; Hein R; Herrmann K; Albrecht M; Bell S; Thur J; Muche R; Adelmann-Grill B; Wehner-Caroli J; Gaus W; Krieg T Arch Dermatol; 1997 May; 133(5):609-13. PubMed ID: 9158414 [TBL] [Abstract][Full Text] [Related]
6. Recombinant interferon-gamma in the treatment of systemic sclerosis. Kahan A; Amor B; Menkes CJ; Strauch G Am J Med; 1989 Sep; 87(3):273-7. PubMed ID: 2505614 [TBL] [Abstract][Full Text] [Related]
7. Treatment of systemic sclerosis with gamma-interferon. Hein R; Behr J; Hündgen M; Hunzelmann N; Meurer M; Braun-Falco O; Urbanski A; Krieg T Br J Dermatol; 1992 May; 126(5):496-501. PubMed ID: 1610690 [TBL] [Abstract][Full Text] [Related]
11. The course of skin involvement in systemic sclerosis over three years in a trial of chlorambucil versus placebo. Clements P; Lachenbruch P; Furst D; Paulus H Arthritis Rheum; 1993 Nov; 36(11):1575-9. PubMed ID: 8240434 [TBL] [Abstract][Full Text] [Related]
12. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial. DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241 [TBL] [Abstract][Full Text] [Related]
13. A short 2 week dose titration regimen reduces the severity of flu-like symptoms with initial interferon gamma-1b treatment. Devane JG; Martin ML; Matson MA Curr Med Res Opin; 2014 Jun; 30(6):1179-87. PubMed ID: 24576196 [TBL] [Abstract][Full Text] [Related]
14. [Therapy of progressive scleroderma with gamma-interferon]. Mensing H Hautarzt; 1991 Jun; 42(6):380-3. PubMed ID: 1917461 [TBL] [Abstract][Full Text] [Related]
15. Interferons and systemic sclerosis: correlation between interferon gamma and interferon-lambda 1 (IL-29). Dantas AT; Gonçalves SM; Pereira MC; de Almeida AR; Marques CD; Rego MJ; Pitta Ida R; Duarte AL; Pitta MG Autoimmunity; 2015; 48(7):429-33. PubMed ID: 26057401 [TBL] [Abstract][Full Text] [Related]
16. A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma. Pope JE; Bellamy N; Seibold JR; Baron M; Ellman M; Carette S; Smith CD; Chalmers IM; Hong P; O'Hanlon D; Kaminska E; Markland J; Sibley J; Catoggio L; Furst DE Arthritis Rheum; 2001 Jun; 44(6):1351-8. PubMed ID: 11407694 [TBL] [Abstract][Full Text] [Related]
17. Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2. Antonelli A; Fallahi P; Ferrari SM; Giuggioli D; Colaci M; Di Domenicantonio A; Ferri C J Rheumatol; 2012 May; 39(5):979-85. PubMed ID: 22422499 [TBL] [Abstract][Full Text] [Related]
18. Eastern cooperative group trial of interferon gamma in metastatic melanoma: an innovative study design. Schiller JH; Pugh M; Kirkwood JM; Karp D; Larson M; Borden E Clin Cancer Res; 1996 Jan; 2(1):29-36. PubMed ID: 9816086 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: a randomized, double-blind, placebo-controlled study. Milanés-Virelles MT; García-García I; Santos-Herrera Y; Valdés-Quintana M; Valenzuela-Silva CM; Jiménez-Madrigal G; Ramos-Gómez TI; Bello-Rivero I; Fernández-Olivera N; Sánchez-de la Osa RB; Rodríguez-Acosta C; González-Méndez L; Martínez-Sánchez G; López-Saura PA; BMC Infect Dis; 2008 Feb; 8():17. PubMed ID: 18267006 [TBL] [Abstract][Full Text] [Related]
20. A pilot study of gamma-1b-interferon in combination with fluorouracil, leucovorin, and alpha-2a-interferon. Grem JL; McAtee N; Murphy RF; Balis FM; Cullen E; Chen AP; Hamilton JM; Steinberg SM; Quinn M; Sorensen JM; Arbuck SG; Lawrence D; Pang J; Allegra CJ Clin Cancer Res; 1997 Jul; 3(7):1125-34. PubMed ID: 9815792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]